Detalhe da pesquisa
1.
50âyears of spondyloarthritis: a look back and a look ahead.
Curr Opin Rheumatol
; 36(4): 261-266, 2024 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38656252
2.
The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study.
Rheumatology (Oxford)
; 63(4): 991-998, 2024 Apr 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37341637
3.
Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritis.
Rheumatology (Oxford)
; 62(2): 606-616, 2023 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35766811
4.
Pro and contra: is synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) a spondyloarthritis variant?
Curr Opin Rheumatol
; 34(4): 209-217, 2022 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35699334
5.
Dactylitis is an indicator of a more severe phenotype independently associated with greater SJC, CRP, ultrasound synovitis and erosive damage in DMARD-naive early psoriatic arthritis.
Ann Rheum Dis
; 81(4): 490-495, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34893470
6.
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial.
Lancet
; 395(10230): 1115-1125, 2020 04 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32178765
7.
Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials.
Ann Rheum Dis
; 80(2): 185-193, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33106286
8.
A clinical and radiographic comparison of patients with psoriatic arthritis from different ethnic backgrounds.
Rheumatology (Oxford)
; 60(1): 340-345, 2021 01 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32778892
9.
Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis.
Rheumatology (Oxford)
; 60(3): 1137-1147, 2021 03 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32864685
10.
Simulation-based design of pragmatic trials in psoriatic arthritis using propensity scores.
Clin Trials
; 18(5): 541-551, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34431409
11.
GRAPPA 2020 Update From the Education Committee.
J Rheumatol Suppl
; 97: 58-59, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-34074669
12.
Updates on Axial Psoriatic Arthritis From the 2020 GRAPPA Annual Meeting.
J Rheumatol Suppl
; 97: 30-33, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-34074663
13.
Pustular Psoriasis and Associated Musculoskeletal Disorders.
J Rheumatol Suppl
; 97: 34-38, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-34074664
14.
Composite Measures for Clinical Trials in Psoriatic Arthritis: Testing Pain and Fatigue Modifications in a UK Multicenter Study.
J Rheumatol Suppl
; 97: 39-44, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-34074665
15.
Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter Study.
J Rheumatol Suppl
; 97: 45-49, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-34074666
16.
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting.
J Rheumatol Suppl
; 97: 4-9, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-34074658
17.
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial.
Ann Rheum Dis
; 79(1): 123-131, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31563894
18.
Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial.
Rheumatology (Oxford)
; 59(4): 807-810, 2020 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31504996
19.
Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1).
Rheumatology (Oxford)
; 59(10): 2774-2784, 2020 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32031665
20.
Outcomes of the 2019 GRAPPA Workshop on Continuous Composite Indices for the Assessment of Psoriatic Arthritis and Membership-recommended Next Steps.
J Rheumatol Suppl
; 96: 11-18, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32482762